Form 4: Microbot Medical Director Acquires 20,000 Stock Options
SEC Form 4 Filing
David James Wilson, a director of Microbot Medical Inc., acquired 20,000 stock options on January 28, 2025, exercisable at $1.93.
Summary
- On January 28, 2025, David James Wilson, a director of Microbot Medical Inc., acquired 20,000 stock options.
- The options have an exercise price of $1.93.
- The options become exercisable on December 17, 2025, and expire on January 28, 2035.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing. It doesn't inherently convey positive or negative sentiment, but rather reports a transaction.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company directors and officers.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of transaction: Director acquired 20,000 stock options. |
| 01/29/2025 | Date of Form 4 filing. |
| 12/17/2025 | Options become exercisable. |
| 01/28/2035 | Options expiration date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.